SGHT Q4 2025 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$20M+6.9% YoY

Gross Profit

$18M87.3% margin

Operating Income

-$4M-18.0% margin

Net Income

-$4M-20.4% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+2.4%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$115M

Total Liabilities

$51M

Stockholders' Equity

$64M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$19M	+6.9%
Gross Profit	$18M	$17M	+7.4%
Operating Income	-$4M	-$12M	+69.2%
Net Income	-$4M	-$12M	+64.9%

Revenue Segments

Surgical Glaucoma

$20M96%

Dry Eye

$724,0004%